Alimentary Tract Research Center, Imam Khomeini hospital clinical research development Unit, The school of medicine, Ahvaz Jundishapur University of Medical sciences, Ahvaz, Iran.
World Endoscopy Organization, emerging star group, Munich, Germany.
Arq Gastroenterol. 2022 Jul-Sep;59(3):358-364. doi: 10.1590/S0004-2803.202203000-65.
The role of dairy foods in inflammatory bowel disease (IBD) has been controversial and it is debatable if patients with IBD should avoid milk and dairy products or not, as well as the relationship between these foods and symptoms among those population.
This multi centric cross-sectional study designed to evaluate if it is really necessary to deprive IBD patients from consumption of dairy foods.
A multicenter study with 12 gastroenterology referral centers in four countries was designed to evaluate gastrointestinal (GI) symptoms after consumption of dairy foods from all outpatients with IBD during 6 months and to compare patients treated at the same centers without IBD (non IBD cases).
Overall 1888 cases included (872 IBD patients and 1016 non IBD cases). 56.6% of participants were female with average age of 40.1 years. Racially 79.8% participants were Caucasians and originally they were citizens of 10 countries. Relative prevalence of IBD was higher in Africans and Indians and the most frequent prevalence of dairy foods intolerance was seen in Asians. Among IBD patients, 571 cases diagnosed as ulcerative colitis and 189 participants as Crohn's disease. Average duration of diagnosis as IBD was 6.8 years (from 2 months to 35 years). The most prevalent GI symptoms after consumption of all the dairy foods were bloating and abdominal pain. Totally, intolerance of dairy foods and lactase deficiency was more prevalent among IBD patients in comparison with non IBD cases (65.5% vs 46.1%, P=0.0001). But the rate of GI complains among IBD patients who had not any family history of lactase deficiency, history of food sensitivity or both were 59.91%, 52.87% & 50.33% respectively and similar to non IBD cases (P=0.68, 0.98 & 0.99 respectively).
The rate of dairy foods intolerance among IBD patients without family history of lactase deficiency or history of food sensitivity is similar to non IBD cases and probably there is no reason to deprive them from this important source of dietary calcium, vitamin D and other nutrients.
乳制品在炎症性肠病(IBD)中的作用一直存在争议,对于 IBD 患者是否应该避免食用牛奶和乳制品,以及这些食物与该人群症状之间的关系,尚无定论。
本多中心横断面研究旨在评估是否真的有必要让 IBD 患者禁食乳制品。
设计了一项多中心研究,纳入来自四个国家的 12 个胃肠病学转诊中心的所有 IBD 门诊患者,在 6 个月内评估他们食用乳制品后的胃肠道(GI)症状,并将其与同一中心的非 IBD 患者(非 IBD 病例)进行比较。
共纳入 1888 例患者(872 例 IBD 患者和 1016 例非 IBD 患者)。参与者中 56.6%为女性,平均年龄为 40.1 岁。种族方面,79.8%为白种人,原籍为 10 个国家。IBD 的相对患病率在非洲人和印度人中较高,而亚洲人中对乳制品不耐受的患病率最高。在 IBD 患者中,571 例被诊断为溃疡性结肠炎,189 例为克罗恩病。IBD 的平均诊断时间为 6.8 年(2 个月至 35 年)。食用所有乳制品后最常见的 GI 症状是腹胀和腹痛。总体而言,IBD 患者对乳制品不耐受和乳糖酶缺乏的发生率高于非 IBD 患者(65.5%比 46.1%,P=0.0001)。但是,在没有乳糖酶缺乏家族史、食物敏感史或两者均无的 IBD 患者中,GI 症状的发生率分别为 59.91%、52.87%和 50.33%,与非 IBD 患者相似(P=0.68、0.98 和 0.99)。
在没有乳糖酶缺乏家族史或食物敏感史的 IBD 患者中,对乳制品不耐受的发生率与非 IBD 患者相似,因此,没有理由让他们禁食这种重要的膳食钙、维生素 D 和其他营养素来源。